Efferocytosis and Inflammation: a Bibliometric and Systematic Analysis

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2025 Feb 25

PMID 39995691

Authors

Xin Cao

Fen Li

Xi Xie

Guanghui Ling

Xiaoyu Tang

Wenfang He

Jing Tian

Yan Ge

Affiliations

Soon will be listed here.

Abstract

Objective: To visualize and analyze the trends and hotspots of efferocytosis and inflammation via bibliometric methods.

Methods: Relevant articles and reviews from 2006 to 2023 were retrieved from the Web of Science Core Collection. The data were processed with CiteSpace, and some graphs were generated with Microsoft Excel (version 2016), VOSviewer, Scimago Graphica, Bibliometrix and R Studio.

Results: A total of 1,003 papers were included, revealing a significant upward trend in efferocytosis and inflammation research. The United States (456, 45.46%), China (164, 16.35%) and the United Kingdom (99, 9.87%) were the three countries with the highest numbers of publications. Harvard University (84, 6.74%) contributes the most out of the top 5 institutions. Among the researchers in this field, Serhan CN was the author with the highest number of articles in the field (35, 3.49%), and deCathelineau AM first named "efferocytosis" in 2003. Keyword analysis identified "activation," "tam receptors," "docosahexaenoic acid" "systemic lupus erythematosus," "myocardial infarction" and "alveolar macrophages" as core topics, indicating a concentrated trend in the mechanism of physiological state and inflammatory diseases such as autoimmune, cardiovascular, and pulmonary diseases. The latest surge words "inflammation resolution" and "cancer" in the keyword heatmap indicate future research directions.

Conclusion: Research on the association between efferocytosis and inflammation has been a promising field. Key areas of focus include the crucial role of efferocytosis on tissue homeostasis and the pathogenesis of nontumorous inflammatory diseases. Future research will likely continue to explore these frontiers, with an emphasis on understanding efferocytosis in the context of chronic diseases and cancer, as well as developing novel therapeutic strategies.

References

Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y . Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004; 304(5674):1147-50. DOI: 10.1126/science.1094359. View

Scott R, McMahon E, Pop S, Reap E, Caricchio R, Cohen P . Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001; 411(6834):207-11. DOI: 10.1038/35075603. View

Baker D, Barth J, Chang R, Obeid L, Gilkeson G . Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. J Immunol. 2010; 185(4):2570-9. PMC: 2942019. DOI: 10.4049/jimmunol.1000644. View

Gude D, Alvarez S, Paugh S, Mitra P, Yu J, Griffiths R . Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. FASEB J. 2008; 22(8):2629-38. PMC: 2493451. DOI: 10.1096/fj.08-107169. View

Hoang D, Pham P, Bach T, Ngo A, Nguyen Q, Phan T . Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022; 7(1):272. PMC: 9357075. DOI: 10.1038/s41392-022-01134-4. View

OBrien B, Geng X, Orteu C, Huang Y, Ghoreishi M, Zhang Y . A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun. 2006; 26(2):104-15. DOI: 10.1016/j.jaut.2005.11.006. View

Zhang M, Johnson-Stephenson T, Wang W, Wang Y, Li J, Li L . Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17 regulatory T cell. Stem Cell Res Ther. 2022; 13(1):484. PMC: 9509559. DOI: 10.1186/s13287-022-03174-7. View

van den Brand B, Abdollahi-Roodsaz S, Vermeij E, Bennink M, Arntz O, Rothlin C . Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis. Arthritis Rheum. 2012; 65(3):671-80. PMC: 3582862. DOI: 10.1002/art.37786. View

Szondy Z, Garabuczi E, Joos G, Tsay G, Sarang Z . Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications. Front Immunol. 2014; 5:354. PMC: 4117929. DOI: 10.3389/fimmu.2014.00354. View

10.

da Silva J, Passos D, Bernardes V, Leal D . ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis. Immunol Lett. 2019; 214:55-64. DOI: 10.1016/j.imlet.2019.08.009. View

11.

Cohen P, Caricchio R, Abraham V, Camenisch T, Jennette J, Roubey R . Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med. 2002; 196(1):135-40. PMC: 2194017. DOI: 10.1084/jem.20012094. View

12.

Truman L, Ford C, Pasikowska M, Pound J, Wilkinson S, Dumitriu I . CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood. 2008; 112(13):5026-36. DOI: 10.1182/blood-2008-06-162404. View

13.

Elliott M, Ravichandran K . The Dynamics of Apoptotic Cell Clearance. Dev Cell. 2016; 38(2):147-60. PMC: 4966906. DOI: 10.1016/j.devcel.2016.06.029. View

14.

Huttunen H, Fages C, Rauvala H . Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem. 1999; 274(28):19919-24. DOI: 10.1074/jbc.274.28.19919. View

15.

Kazeros A, Harvey B, Carolan B, Vanni H, Krause A, Crystal R . Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers. Am J Respir Cell Mol Biol. 2008; 39(6):747-57. PMC: 2586050. DOI: 10.1165/rcmb.2007-0306OC. View

16.

Lv H, Hua Q, Wang Y, Gao Z, Liu P, Qin D . Mapping the knowledge structure and emerging trends of efferocytosis research: a bibliometric analysis. Am J Transl Res. 2023; 15(2):1386-1402. PMC: 10006791. View

17.

Zheng C, Sui B, Zhang X, Hu J, Chen J, Liu J . Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes. J Extracell Vesicles. 2021; 10(7):e12109. PMC: 8144839. DOI: 10.1002/jev2.12109. View

18.

Doran A, Yurdagul Jr A, Tabas I . Efferocytosis in health and disease. Nat Rev Immunol. 2019; 20(4):254-267. PMC: 7667664. DOI: 10.1038/s41577-019-0240-6. View

19.

Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I . Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem. 2011; 286(38):33335-44. PMC: 3190938. DOI: 10.1074/jbc.M111.263020. View

20.

Gromovsky A, Schugar R, Brown A, Helsley R, Burrows A, Ferguson D . Δ-5 Fatty Acid Desaturase Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators. Arterioscler Thromb Vasc Biol. 2017; 38(1):218-231. PMC: 5746431. DOI: 10.1161/ATVBAHA.117.309660. View